E. Benjamin

发表

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

D. Oram, M. Parmar, I. Jacobs, 2016, The Lancet.

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Sebastian M. Armasu, Yurii B. Shvetsov, A. Whittemore, 2013, Nature Communications.

Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

Francesmary Modugno, Christine Chow, Ellen L Goode, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Outcome of risk‐reducing salpingo‐oophorectomy in BRCA carriers and women of unknown mutation status

D. Oram, I. Jacobs, U. Menon, 2011, BJOG : an international journal of obstetrics and gynaecology.

Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar

I. Jacobs, U. Menon, A. Ryan, 2020, Trials.

In vitro three‐dimensional modelling of human ovarian surface epithelial cells

I. Jacobs, E. Benjamin, S. Gayther, 2009, Cell proliferation.

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.

I. Jacobs, U. Menon, E. Benjamin, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diathermy-Induced Injury May Affect Detection of Occult Tubal Lesions at Risk-Reducing Salpingo-Oophorectomy

I. Jacobs, U. Menon, M. Burnell, 2012, International Journal of Gynecologic Cancer.

Haemangioblastoma of a cervical sensory nerve root in Von Hippel-Lindau syndrome

A. McEvoy, E. Benjamin, M. Powell, 2000, European Spine Journal.

Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS)

I. Jacobs, U. Menon, E. Benjamin, 2012, Archives of Gynecology and Obstetrics.

Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.

P. Laird, A. Berchuck, I. Jacobs, 2010, Neoplasia.

Three‐dimensional in vitro cell biology models of ovarian and endometrial cancer

I. Jacobs, E. Benjamin, S. Gayther, 2009, Cell proliferation.

In vitro three-dimensional modeling of fallopian tube secretory epithelial cells

I. Jacobs, E. Benjamin, S. Gayther, 2013, BMC Cell Biology.

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

M. Beckmann, P. Fasching, R. Vierkant, 2014, British Journal of Cancer.

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.

A. Whittemore, R. Vierkant, M. García-Closas, 2013, The Lancet. Oncology.

Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.

I. Jacobs, E. Benjamin, S. Gayther, 2011, Carcinogenesis.

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

Matthew Burnell, Martin Widschwendter, Tim Mould, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer.

I. Jacobs, E. Benjamin, S. Gayther, 2010, Neoplasia.

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study

I. Jacobs, U. Menon, A. Ryan, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oxidation of Ovarian Epithelial Cancer Cells by Hypochlorous Acid Enhances Immunogenicity and Stimulates T Cells that Recognize Autologous Primary Tumor

J. Ledermann, E. Benjamin, B. Chain, 2008, Clinical Cancer Research.

Risk of epithelial ovarian cancer in asymptomatic women with ultrasound‐detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)

D. Oram, I. Jacobs, M. Parmar, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Evidence of stage-shift in women diagnosed with ovarian cancer during Phase 2 of the UK Familial Ovarian Cancer Screening Study (UKFOCSS)

I. Jacobs, U. Menon, A. Ryan, 2016 .

Can high histological confirmation rates be achieved for pelvic endometriosis?

E. Benjamin, E. Sarıdoğan, A. Cutner, 2009, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Factors influencing uptake and timing of risk reducing salpingo‐oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis

D. Oram, I. Jacobs, I. Jacobs, 2012, BJOG : an international journal of obstetrics and gynaecology.

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.

I. Jacobs, U. Menon, E. Benjamin, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

R. Vierkant, B. Fridley, E. Goode, 2013, Cancer Epidemiology, Biomarkers & Prevention.

In vitro three‐dimensional modelling of human ovarian surface epithelial cells

E. Benjamin, S. Gayther, D. Dafou, 2009, Cell proliferation.